✦ LIBER ✦

Lead Optimization of 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A 2A Adenosine Receptor Antagonists for the Treatment of Parkinson’s Disease

✍ Scribed by Zhang, Xiaohu; Tellew, John E.; Luo, Zhiyong; Moorjani, Manisha; Lin, Emily; Lanier, Marion C.; Chen, Yongsheng; Williams, John P.; Saunders, John; Lechner, Sandra M.; Markison, Stacy; Joswig, Tanya; Petroski, Robert; Piercey, Jaime; Kargo, William; Malany, Siobhan; Santos, Mark; Gross, Raymond S.; Wen, Jenny; Jalali, Kayvon; O’Brien, Zhihong; Stotz, Carol E.; Crespo, María I.; Díaz, José-Luis; Slee, Deborah H.

Book ID: 120345630
Publisher: American Chemical Society
Year: 2008
Tongue: English
Weight: 271 KB
Volume: 51
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm800851u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adenosine A2A receptor antagonists as ne

Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease

✍ P.J. Richardson; H. Kase; P.G. Jenner 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Adenosine A2A receptor antagonists as ne

Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease

✍ Peter J. Richardson; Hiroshi Kase; Peter G. Jenner 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 896 KB

Synthesis and Biological Evaluation of M

Synthesis and Biological Evaluation of Metabolites of 2- n -Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9 H -purin-6-ylamine (ST1535), A Potent Antagonist of the A 2A Adenosine Receptor for the Treatment of Parkinson’s Disease

✍ Piersanti, Giovanni; Bartoccini, Francesca; Lucarini, Simone; Cabri, Walter; Sta 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 537 KB

Pharmacological characterisation and inh

Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A2A receptor agonist and adenosine A3 receptor antagonist activity

✍ Nicola Bevan; Peter R. Butchers; Rick Cousins; Jill Coates; Emma V. Edgar; Val M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 241 KB

Development of 5-(3-alkenyl-1,2,4-oxadia

Development of 5-(3-alkenyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine derivatives as selective muscarinic agonists for the treatment of Alzheimer's disease

✍ H. Zhang; B. Ojo; X.-P. Huang; M.A.N. Edgar; A.A. El-Assadi; D. Baril; K. Lynch; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Structure and absolute configuration of

Structure and absolute configuration of a high affinity 5-HT3 receptor antagonist, (5aS,9aS)-N-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-2-chloro-5a,6,7,8,9,9a-hexahydro-4-dibenzofurancarboxamide hydrochloride

✍ Ammon, H. L. ;Youssefyeh, R. D. ;Airey, J. E. ;Studt, W. L. ;Campbell, H. F. ;Po 📂 Article 📅 1993 🏛 International Union of Crystallography 🌐 English ⚖ 458 KB